NASDAQ:INTS News 30 October 2025

Tiny Biotech INTENSITY THERAPEUTICS Stock Skyrockets on Cancer Therapy Breakthrough – Experts See Big Upside

Stock Rally on Novel Cancer Data Intensity Therapeutics (NASDAQ: INTS) has been one of the market’s biggest movers. On Oct. 30, 2025 its stock was around $0.27 per share investing.com – an 84% drop YTD but up nearly 200% intraday on the news of its Lancet-published trial tipranks.com. Trading volume exploded: ~279 million shares traded on Oct. 30 vs. an average of ~5 M per day tipranks.com. The rally was sparked by the Phase 1/2 study announcement that Intensity’s lead drug, INT230‑6, showed striking tumor control in advanced cancer. The study covered 64 patients across 20+ tumor types – most had failed multiple therapies.

30 October 2025

NASDAQ:INTS·Stock Market

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 30.10.2025

ENDEDLive coverage has endedEnded: October 31, 2025, 12:00 AM EDT Liberty Latin America (LILA) Valuation Under Scrutiny as Shares Slide Despite Solid Fundamentals October 30, 2025, 10:36 PM EDT. Liberty Latin America (LILA) has fallen ~6% over the last month despite solid annual revenue growth and a rebound in net income. Its 1-year total shareholder return is down >20%, even after a strong rally earlier this year and a ~21% YTD gain. The stock trades at a discount to analyst targets, with a fair value around $10.63 versus a recent close near $7.77, suggesting an undervalued setup for patient investors.

30 October 2025

NASDAQ:GOOGL·NASDAQ:INTS·NASDAQ:LILA·NASDAQ:META·NASDAQ:MSFT·NYSE:FMC·NYSE:ORCL·Stock Market

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026

Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026

Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026

MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.

LONGi Green Energy stock in focus: 1.65 bln yuan patent fee signals higher costs as China solar outlook softens

8 February 2026

LONGi Green Energy’s Shanghai A-shares closed up 0.7% at 18.36 yuan on Friday after a 1.65 billion yuan BC solar patent licensing deal was disclosed this week. The agreement, involving Aiko Solar and Maxeon, set a price for key solar IP as industry forecasts point to a drop in China’s 2026 new solar installations.